Portfolio (Quarterly)
Guide ↗
Candriam S.C.A.
· CIK 0001537014| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 181 | MEDP | MEDPACE HLDGS INC | Healthcare | 39,035.0 | $21.9M | 0.11% | +22K | +126.7% | $561.67 | -15.7% |
| 182 | BBIO | BRIDGEBIO PHARMA INC | Healthcare | 278,888.0 | $21.3M | 0.11% | +130K | +87.2% | $76.49 | -10.3% |
| 183 | KMB | KIMBERLY-CLARK CORP | Consumer Defensive | 211,103.0 | $21.3M | 0.11% | +189K | +834.3% | $100.89 | +3.0% |
| 184 | DE | DEERE & CO | Industrials | 45,360.0 | $21.1M | 0.10% | +23K | +104.1% | $465.59 | +27.1% |
| 185 | VLTO | VERALTO CORP | Industrials | 210,965.0 | $21.1M | 0.10% | -31K | -12.9% | $99.78 | -16.9% |
| 186 | CAT | CATERPILLAR INC | Industrials | 36,497.0 | $20.9M | 0.10% | +4K | +11.8% | $572.89 | +71.8% |
| 187 | DYN | DYNE THERAPEUTICS INC | Healthcare | 1,057,263.0 | $20.7M | 0.10% | +223K | +26.8% | $19.56 | +3.6% |
| 188 | EW | EDWARDS LIFESCIENCES CORP | Healthcare | 234,968.0 | $20.0M | 0.10% | +173K | +279.0% | $85.25 | +2.0% |
| 189 | NKE | NIKE INC | Consumer Cyclical | 308,983.0 | $19.7M | 0.10% | +158K | +104.1% | $63.71 | -33.5% |
| 190 | DECK | DECKERS OUTDOOR CORP | Consumer Cyclical | 188,303.0 | $19.5M | 0.10% | +82K | +77.5% | $103.67 | -0.0% |
| 191 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 925,332.0 | $19.4M | 0.10% | — | — | $21.01 | -6.7% |
| 192 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 1,166,379.0 | $19.3M | 0.10% | +333K | +39.9% | $16.51 | +50.0% |
| 193 | SOLS | SOLSTICE ADVANCED MATLS INC | Basic Materials | 18,557.0 | $19.2M | 0.10% | NEW | — | $1032.26 | -91.8% |
| 194 | AMAT | APPLIED MATLS INC | Technology | 73,666.0 | $18.9M | 0.09% | -106K | -59.0% | $257.00 | +128.0% |
| 195 | PODD | INSULET CORP | Healthcare | 66,502.0 | $18.9M | 0.09% | +30K | +83.3% | $284.25 | -49.4% |
| 196 | PYPL | PAYPAL HLDGS INC | Financial Services | 323,447.0 | $18.9M | 0.09% | -300K | -48.1% | $58.38 | -28.6% |
| 197 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 790,613.0 | $18.8M | 0.09% | +412K | +108.9% | $23.83 | +18.2% |
| 198 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 417,402.0 | $18.7M | 0.09% | +21K | +5.2% | $44.82 | +22.2% |
| 199 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 799,384.0 | $18.4M | 0.09% | +45K | +5.9% | $23.00 | +25.0% |
| 200 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 468,556.0 | $17.9M | 0.09% | -44K | -8.6% | $38.21 | +46.4% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
34.2%
Healthcare
25.8%
Financial Services
11.2%
Consumer Cyclical
8.0%
Communication Services
7.2%
Industrials
5.5%
Consumer Defensive
2.6%
Utilities
1.7%
Basic Materials
1.5%
Real Estate
1.4%